Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Budget Plan: $1 Bil. Increase For Administrative Activities Is New, But Drug Policy Proposals Are Old

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS budget plan reprises Medicare drug rebates for dual eligibles, eliminating brand/generic patent settlements and other unsuccessful Rx proposals.

Advertisement

Related Content

Biologics Exclusivity: GPhA Making Last Stand In Pacific
Amid Uncertainties, Acorda Preps For Next Phase Of ACA: An Interview With Managed Markets Head Kent Rogers
IPAB Raised At Debate, But Romney Advisor Skeptical Board Will Meet Even If Obama Wins
Medicare Reform Using Part D Model Is Advocacy Priority For PhRMA – Castellani
Medicare Reform Using Part D Model Is Advocacy Priority For PhRMA – Castellani
Once Burned, Twice Shy? Pharma Urged To Engage On Entitlement Reform
Part D Rebates Would Contribute More Than Half Of Medicare Savings In White House Plan
Planning For Exchanges: Pharma Hopes For “Broad Enrollment,” But Timeline Causes Concern
Three Ways IPAB Can Reduce Drug Costs In Medicare: An Interview With Scott Gottlieb
CMS 2012 Budget Looks To Biosimilars, Brand/Generic Deals To Offset Costs

Topics

Advertisement
UsernamePublicRestriction

Register

PS073751

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel